The journal «Practical oncology»
- №99 Хирургические аспекты лечения опухолей печени
- №98 Main events in oncology in 2022
- №97 Neoadjuvant and adjuvant therapy. What changed?
- №96 Паллиативное и симптоматическое лечение
- №95 History of oncology
- №94 Main events in oncology in 2022
- №93 Innovations in diagnostics
- №92 Альтернативные мишени лекарственной терапии
- №91 Immunotherapy : What can? What to expect? What to beware of?
- №90 Main events in oncology in 2021
- №89 Local treatment in the era of systemic therapy
- №88 Tumor microenvironment as the main therapeutic target
- №87 Problems of Tumor Resistance to Drug Therapy
- №86 Main achievements in oncology in 2020
- №85 Unsolved issues of surgical oncology
- №84 The role of a multidisciplinary medical consilium in oncology
- №83 Practical problems of modern oncology in Russia
- №82 Main events in oncology in 2019
- №81 Promising targets in cancer treatment
- №80 Hepatocellular carcinoma
- №79 UROLOGICAL CANCERS DEVELOPEMENT
- №78 The most important events in Oncology in 2018
- №77 Virus-associated tumors
- №76 Critical view on the development of oncology in the last 20 years
- №75 Lung cancer
- №74 The most important events in Oncology in 2017
- №73 What you need to know practical oncom?
- №72 Breast cancer. New in the last five years
- №71 Cancer in young age
- №70 The most important achievements in oncology in 2016
- №69 Interdisciplinary approach for the diagnosis, treatment and prevention of colorectal cancer
- №68 Possible ways to reduce cancer mortality
- №67 Cytoreductive surgery in disseminated tumors
- №66 Cancer immunotherapy
- №65 The most important achievements in oncology in 2015
- №64 Locoregional therapy: a promising method for cancer treatment
- №63 Treatment of malignant tumors in elderly patients
- №62 Interdisciplinary approach for cancer treatment
- №61 The most important achievements in oncology in 2014
- №60 Ovarian cancer
- №59 Hereditarycancersyndromes
- №58 Controversial issues in oncology
- №57 The most important achievements in oncology in 2013
- №56 Individualization of chemotherapy in cancer patients
- №55 Primary tumors of the central nervous system
- №54 Soft tissue and visceral sarcomas
- №53 The most important achievements in oncology in 2012
- №52 Chemotherapy of gastrointestinal tumors
- №51 Promising methods of surgical treatment in oncological urology
- №50 Skin tumors
- №49 The most important achievements in oncology in 2011
- №48 Biomarkers in oncology
- №47 Skeletal disorders in cancer patients
- №46 Cancer prevention
- №45 The most important achievements in oncology in 2010
- №44 Breast cancer
- №43 Targeted cancer therapy
- №42 Cancer screening
- №41 Bone sarcomas
- №40 Malignant tumors and pregnancy
- №39 Palliative and supportive care in cancer patients
- №38 Topical issues in oncological gynecology
- №37 Gastric cancer
- №36 Hepatic tumors
- №35 Malignant non-epithelial tumors of the uterine (sarcomas, trophoblastic disease)
- №34 Prostate cancer
- №33 Cancer chemoradiotherapy
- №32 Promising diagnostic and treatment methods in oncology
- №31 Theoretical background of adjuvant cancer therapy
- №30 Hodgkin's lymphomas
- №29 Thyroid cancer
- №28 Vulva and vagina tumors
- №27 Non-small cell lung cancer and mesothelioma
- №26 Oncological emergencies
- №25 Germ cell tumors
- №24 Neuroendocrine tumors
- №23 Renal parenchyma tumors
- №22 Colorectal cancer
- №21 The most important achievements in oncology in 2004
- №20 Extraorgan sarcoma of the soft tissues
- №19 Non-Hodgkin's lymphomas
- №18 Pancreatic cancer
- №17 Uterine cancer
- №16 Bladder cancer
- №15 Biotherapy of malignant tumors
- №14 Esophageal cancer
- №13 Squamous cell carcinoma of the head and neck
- №12 Promising chemotherapy methods for cancer treatment
- №11 Cervical cancer
- №10 Rectal cancer
- №9 Operable breast cancer
- №8 Melanoma
- №7 Gastric cancer
- №6 Prostate cancer
- №5 Palliative and symptomatic treatment for patients with cancer
- №4 Ovarian cancer
- №3 Non-small cell lung cancer
- №2 Breast cancer
- №1 Colon cancer